Top compounds associated with response to RP11-178C3.1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.01
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.14 0.01
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA IU1 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.075 0.02
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.085 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.03
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.03
Download CSV